File: D:/hMailServer/Data/sarahharvey.com/bob/25/{25FB659B-C63D-4B7A-8172-C88D5017FDCD}.eml
Received: from c145-150.smtp-out.us-west-2.amazonses.com (c145-150.smtp-out.us-west-2.amazonses.com [76.223.145.150])
by mail.itpartnership.com with ESMTPS
(version=TLSv1.3 cipher=TLS_AES_128_GCM_SHA256 bits=128)
; Tue, 23 Jun 2026 18:51:39 +0100
Reply-To: <thebusinessinvestor1@gmail.com>
From: "The Business Investor" <thebusinessinvestor1@email.thebusinessinvestor.co.uk>
To: <bob@sarahharvey.com>
Subject: Tax-efficient investment | Cancer diagnostics laboratory
Date: Tue, 23 Jun 2026 18:51:36 +0100
Message-ID: <0101019ef59beab7-8401cac2-fbf1-46f7-a2c4-b9caf03dbb0f-000000@us-west-2.amazonses.com>
MIME-Version: 1.0
Content-Type: multipart/alternative;
boundary="----=_NextPart_000_16FC_01DD0882.AE814120"
X-Mailer: Microsoft Outlook 16.0
List-Unsubscribe: <https://t.email.thebusinessinvestor.co.uk/u/2/UDJYrQvimamIVjBvyCx_ag/Fgp-C--y6adamaSdNtNqFWCPKJfzH_1MFACwnmC3BgChG9TcAirPEYQMRm7aA9S4m3fwSOBLPUFfhnvUqRiADo55-9mwAwhA9m2GmTcb4NS0-nUFNasNpgyDx6lzhSOT_wVejKaJ_pu8JLGc1639GlskKB_bTw1gRXERncnUKsvILFV1sthPhvtrXuMfjI0f9GszM_Msr5jj1T4E1iDKXtbQkczE7OHyo0yZoz8reQv7S-DnqRJMJcfLKn5V4FYTHo-UtvTsrX0T8h9xHmAx1g>
Thread-Index: AQEsjcXbFVp3rArbPPRvBbSW5T2LQw==
X-SES-Outgoing: 2026.06.23-76.223.145.150
x-env-meta: 2:GhZHvxiinjHXAAy1KUBm6A:rwuAbYlrVN3NWdI2RDjCTI1dfBAP4VvCKgJCsL4gQMUhIdQjNdwnxn1TSSpZ54EbEd71bd3e7ADwnwmegqOu8l58GvMtnWNVjymixgyFexZkyHlLhiRfFrj5hlF0VXTAI9LefvRIxX62tFQgvPEj1xkhzGQe3Yog7iaKQIGfnVnY0Hyr7c0tat8z_P7tQsn3
X-OlkEid: 00000000CC09373165EA424894A88D7C135300090700C3B68E10F77511CEB4CD00AA00BBB6E600000000000B0000F3CAA7D39DC9FE498D8F5D237175EB7800000000C89700004D9D15A2957F6C4A9E3E5C9ED180754E
This is a multipart message in MIME format.
------=_NextPart_000_16FC_01DD0882.AE814120
Content-Type: text/plain;
charset="UTF-8"
Content-Transfer-Encoding: 7bit
Successful cancer screening lab EIS approved
Hello,
We are pleased to share an opportunity to invest in the next generation of
cancer screening, while benefiting from generous tax incentives available to
company directors.
Frontier Diagnostics is at the forefront of cancer screening and is seeking
investors to help transform the landscape of cancer detection and treatment.
Investment Highlights:
* Diagnostics platform built on ISO-accredited laboratory infrastructure
* Clinics send us the samples, and we return results in 5 days
* Larger sites can use our Quantum Fluoscope device for in-house testing
* Huge market potential with a worldwide sales pipeline in place
* and much more...
EIS approved efficiencies:
* 30% Income Tax Relief*
* Free from Capital Gains*
* Inheritance Tax Relief*
* Loss Relief*
If the above is of interest, please let us know by replying to this email or
filling in our online form
<https://t.email.thebusinessinvestor.co.uk/a/2/BWAfi9ZMEYg0bephbJWC9w/h9CLbVqN8aMrha51zLHmlBlWEDRCVwff_Hw6x7uTi5bubHEsLvVe7o5RSfSU66w7HPWIVuHajfBu57G9clWoVu_ZSP4U7grUuk167BxnZiTi4SJ8Rm--BMXaR7oK-xTX-A7qWdBbmwSmMHxA4TQ4Bw>
.
Kind regards,
The Business Investor
*If applicable
Disclaimer: Any person accessing the email and considering potential
investment opportunities featured in the email should make their own
commercial assessment after seeking the advice of an appropriately
authorised or regulated financial adviser. This email should not be
construed as advice or a personal recommendation to any prospective
investor. Investments of this nature carry risks to your capital and can go
up or down. Past performance is not indicative of future results. This
opportunity is only suitable for high net worth or self-sophisticated
investors as defined below. You have an annual income in excess of ?100K.
Have net assets in excess of ?250K (excluding your pension funds and assets
and your private residence). You have been a Director of a company turning
over at least ?1 million within the last two years. You have made more than
one investment in an unlisted company in the previous two years. You have
been a member of a network or syndicate of business angels for at least six
months. You have worked in the last two years in a professional capacity in
the private equity sector or in the provision of finance for small and
medium enterprises.
<https://t.email.thebusinessinvestor.co.uk/t/2/IGDZOk1ySvSqUoJY4RgIXQ/PcKeWd47Kank8jXdULSpe7cAlGKZ-aYJswAL2XmwpVkGT1vWX-PQRzz-IRsMlesyAkZ8x1ajWLq1bi4Vcx7PCgbnNrmKBhUfpwBiPx99qzkeJJvABd4hoqMqnILf_-6ZeqS1w1O45w2SSuSwCrlPZwJm1Ek3cVFHW-6wfTaueos>
Unsubscribe
<https://t.email.thebusinessinvestor.co.uk/u/2/UDJYrQvimamIVjBvyCx_ag/Fgp-C--y6adamaSdNtNqFWCPKJfzH_1MFACwnmC3BgChG9TcAirPEYQMRm7aA9S4m3fwSOBLPUFfhnvUqRiADo55-9mwAwhA9m2GmTcb4NS0-nUFNasNpgyDx6lzhSOT_wVejKaJ_pu8JLGc1639GlskKB_bTw1gRXERncnUKsvILFV1sthPhvtrXuMfjI0f9GszM_Msr5jj1T4E1iDKXtbQkczE7OHyo0yZoz8reQv7S-DnqRJMJcfLKn5V4FYTHo-UtvTsrX0T8h9xHmAx1g>
Report Abuse
<https://t.email.thebusinessinvestor.co.uk/s/2/1YobQm-K74m2weCeJuG4AQ/DFaWgeRop2RPS-o7CGi8lSL83l3pYixz7tC5nlJ_21UPEnqQLG-GF1NUC1EcO2ldBUjwMYY-mbCX1V55VTiHPkXUNV5wZKCpahDYNbAXQUmS6VlDS6_ZiRoSOAd5e78_ZkjeMckW4EUdUG89sE1Bn8vcTA3gD0lTHxVjXgn-kWRUAC2L7zgqFKcsgni4MZxCh6LpQZY_-dYbfFABrQEiWugtHPqwQIjqlfe5bDUW5rdCgtdCZgofYRkh60Thz6k9i8PoTLrKw3_xAzXAzSQ-og>
------=_NextPart_000_16FC_01DD0882.AE814120
Content-Type: text/html;
boundary="----=_Part_1025535_1586993227.1782237096631";
charset="UTF-8"
Content-Transfer-Encoding: quoted-printable
<!DOCTYPE html><html xmlns=3D"http://www.w3.org/1999/xhtml" =
xmlns:v=3D"urn:schemas-microsoft-com:vml" =
xmlns:o=3D"urn:schemas-microsoft-com:office:office"><head>
<!--[if gte mso 9]>
<xml>
<o:OfficeDocumentSettings>
<o:AllowPNG/>
<o:PixelsPerInch>96</o:PixelsPerInch>
</o:OfficeDocumentSettings>
</xml>
<![endif]-->
<meta http-equiv=3D"Content-Type" content=3D"text/html; =
charset=3DUTF-8">
<meta name=3D"viewport" content=3D"width=3Ddevice-width, =
initial-scale=3D1.0">
<meta name=3D"x-apple-disable-message-reformatting">
<!--[if !mso]><!--><meta http-equiv=3D"X-UA-Compatible" =
content=3D"IE=3Dedge"><!--<![endif]-->
<title></title>
=20
<style type=3D"text/css">
=20
@media only screen and (min-width: 520px) {
.u-row {
width: 500px !important;
}
.u-row .u-col {
vertical-align: top;
}
=20
.u-row .u-col-100 {
width: 500px !important;
}
=20
}
@media only screen and (max-width: 520px) {
.u-row-container {
max-width: 100% !important;
padding-left: 0px !important;
padding-right: 0px !important;
}
.u-row {
width: 100% !important;
}
.u-row .u-col {
display: block !important;
width: 100% !important;
min-width: 320px !important;
max-width: 100% !important;
}
.u-row .u-col > div {
margin: 0 auto;
}
}
=20
body{margin:0;padding:0}table,td,tr{border-collapse:collapse;vertical-ali=
gn:top}.ie-container table,.mso-container =
table{table-layout:fixed}*{line-height:inherit}a[x-apple-data-detectors=3D=
true]{color:inherit!important;text-decoration:none!important}
table, td { color: #000000; } #u_body a { color: #0000ee; =
text-decoration: underline; }
</style>
=20
=20
<!--[if !mso]><!--><link =
href=3D"https://fonts.googleapis.com/css?family=3DMontserrat:400,700" =
rel=3D"stylesheet" type=3D"text/css"><!--<![endif]-->
</head>
<body class=3D"clean-body u_body" style=3D"margin: 0;padding: =
0;-webkit-text-size-adjust: 100%;background-color: #F7F8F9;color: =
#000000"><div style=3D"display:none; max-height:0; overflow:hidden; =
mso-hide:all; visibility:hidden;">Successful cancer screening lab EIS =
approved</div>
<!--[if IE]><div class=3D"ie-container"><![endif]-->
<!--[if mso]><div class=3D"mso-container"><![endif]-->
<table role=3D"presentation" id=3D"u_body" style=3D"border-collapse: =
collapse;table-layout: fixed;border-spacing: 0;mso-table-lspace: =
0pt;mso-table-rspace: 0pt;vertical-align: top;min-width: 320px;Margin: 0 =
auto;background-color: #F7F8F9;width:100%" cellpadding=3D"0" =
cellspacing=3D"0">
<tbody>
<tr style=3D"vertical-align: top">
<td style=3D"word-break: break-word;border-collapse: collapse =
!important;vertical-align: top">
<!--[if (mso)|(IE)]><table role=3D"presentation" width=3D"100%" =
cellpadding=3D"0" cellspacing=3D"0" border=3D"0"><tr><td =
align=3D"center" style=3D"background-color: #F7F8F9;"><![endif]-->
=20
=20
=20
<div class=3D"u-row-container" style=3D"padding: 0px;background-color: =
transparent">
<div class=3D"u-row" style=3D"margin: 0 auto;min-width: =
320px;max-width: 500px;overflow-wrap: break-word;word-wrap: =
break-word;word-break: break-word;background-color: transparent;">
<div style=3D"border-collapse: collapse;display: table;width: =
100%;height: 100%;background-color: transparent;">
<!--[if (mso)|(IE)]><table role=3D"presentation" width=3D"100%" =
cellpadding=3D"0" cellspacing=3D"0" border=3D"0"><tr><td =
style=3D"padding: 0px;background-color: transparent;" =
align=3D"center"><table role=3D"presentation" cellpadding=3D"0" =
cellspacing=3D"0" border=3D"0" style=3D"width:500px;"><tr =
style=3D"background-color: transparent;"><![endif]-->
=20
<!--[if (mso)|(IE)]><td align=3D"center" width=3D"500" style=3D"width: =
500px;padding: 0px;border-top: 0px solid transparent;border-left: 0px =
solid transparent;border-right: 0px solid transparent;border-bottom: 0px =
solid transparent;border-radius: 0px;-webkit-border-radius: 0px; =
-moz-border-radius: 0px;" valign=3D"top"><![endif]-->
<div class=3D"u-col u-col-100" style=3D"max-width: 320px;min-width: =
500px;display: table-cell;vertical-align: top;">
<div style=3D"height: 100%;width: 100% !important;border-radius: =
0px;-webkit-border-radius: 0px; -moz-border-radius: 0px;">
<!--[if (!mso)&(!IE)]><!--><div style=3D"box-sizing: border-box; =
height: 100%; padding: 0px;border-top: 0px solid =
transparent;border-left: 0px solid transparent;border-right: 0px solid =
transparent;border-bottom: 0px solid transparent;border-radius: =
0px;-webkit-border-radius: 0px; -moz-border-radius: =
0px;"><!--<![endif]-->
=20
<table style=3D"font-family:arial,helvetica,sans-serif;" =
role=3D"presentation" cellpadding=3D"0" cellspacing=3D"0" width=3D"100%" =
border=3D"0">
<tbody>
<tr>
<td =
style=3D"overflow-wrap:break-word;word-break:break-word;padding:10px;font=
-family:arial,helvetica,sans-serif;" align=3D"left">
=20
<div style=3D"font-size: 14px; line-height: 140%; text-align: left; =
word-wrap: break-word;">
<p style=3D"line-height: 140%; margin: 0px;"><span =
style=3D"font-family: Montserrat, sans-serif; line-height: =
19.6px;"><strong>Hello,</strong></span></p>
<p style=3D"line-height: 140%; margin: 0px;"> </p>
<p style=3D"line-height: 140%; margin: 0px;"><span style=3D"font-family: =
Montserrat, sans-serif; line-height: 19.6px;">We are pleased to share an =
opportunity to invest in the next generation of cancer screening, while =
benefiting from generous tax incentives available to company =
directors.</span></p>
<p style=3D"line-height: 140%; margin: 0px;"> </p>
<p style=3D"line-height: 140%; margin: 0px;"><span style=3D"font-family: =
Montserrat, sans-serif; line-height: 19.6px;"><strong>Frontier =
Diagnostics</strong> is at the forefront of cancer screening and is =
seeking investors to help transform the landscape of cancer detection =
and treatment.</span></p>
<p style=3D"line-height: 140%; margin: 0px;"> </p>
<p style=3D"line-height: 140%; margin: 0px;"><span style=3D"font-family: =
Montserrat, sans-serif; line-height: 19.6px;"><strong>Investment =
Highlights:</strong></span></p>
<ul>
<li style=3D"line-height: 19.6px; font-family: Montserrat, =
sans-serif;"><span style=3D"font-family: Montserrat, sans-serif; =
line-height: 19.6px;">Diagnostics platform built on =
<strong>ISO-accredited laboratory infrastructure</strong></span></li>
<li style=3D"line-height: 19.6px; font-family: Montserrat, =
sans-serif;"><span style=3D"font-family: Montserrat, sans-serif; =
line-height: 19.6px;">Clinics send us the samples, and we return results =
in <strong>5 days</strong></span></li>
<li style=3D"line-height: 19.6px; font-family: Montserrat, =
sans-serif;"><span style=3D"font-family: Montserrat, sans-serif; =
line-height: 19.6px;">Larger sites can use our <strong>Quantum Fluoscope =
device</strong> for in-house testing</span></li>
<li style=3D"line-height: 19.6px; font-family: Montserrat, =
sans-serif;"><span style=3D"font-family: Montserrat, sans-serif; =
line-height: 19.6px;">Huge market potential with a <strong>worldwide =
sales pipeline</strong> in place</span></li>
<li style=3D"line-height: 19.6px; font-family: Montserrat, =
sans-serif;"><span style=3D"font-family: Montserrat, sans-serif; =
line-height: 19.6px;">and much more...</span></li>
</ul>
<p style=3D"line-height: 140%; margin: 0px;"><span style=3D"font-family: =
Montserrat, sans-serif; line-height: 19.6px;"><strong>EIS approved =
efficiencies:</strong></span></p>
<ul>
<li style=3D"line-height: 19.6px; font-family: Montserrat, =
sans-serif;"><span style=3D"font-family: Montserrat, sans-serif; =
line-height: 19.6px;">30% Income Tax Relief*</span></li>
<li style=3D"line-height: 19.6px; font-family: Montserrat, =
sans-serif;"><span style=3D"font-family: Montserrat, sans-serif; =
line-height: 19.6px;">Free from Capital Gains*</span></li>
<li style=3D"line-height: 19.6px; font-family: Montserrat, =
sans-serif;"><span style=3D"font-family: Montserrat, sans-serif; =
line-height: 19.6px;">Inheritance Tax Relief*</span></li>
<li style=3D"line-height: 19.6px; font-family: Montserrat, =
sans-serif;"><span style=3D"font-family: Montserrat, sans-serif; =
line-height: 19.6px;">Loss Relief*</span></li>
</ul>
<p style=3D"line-height: 140%; margin: 0px;"><span style=3D"font-family: =
Montserrat, sans-serif; line-height: 19.6px;">If the above is of =
interest, please let us know by<strong> replying to this email</strong> =
or <strong>filling in our </strong><a rel=3D"noopener" =
href=3D"https://t.email.thebusinessinvestor.co.uk/a/2/BWAfi9ZMEYg0bephbJW=
C9w/h9CLbVqN8aMrha51zLHmlBlWEDRCVwff_Hw6x7uTi5bubHEsLvVe7o5RSfSU66w7HPWIV=
uHajfBu57G9clWoVu_ZSP4U7grUuk167BxnZiTi4SJ8Rm--BMXaR7oK-xTX-A7qWdBbmwSmMH=
xA4TQ4Bw" target=3D"_blank">online form</a>.</span></p>
<p style=3D"line-height: 140%; margin: 0px;"> </p>
<p style=3D"line-height: 140%; margin: 0px;"><span style=3D"font-family: =
Montserrat, sans-serif; line-height: 19.6px;"><strong>Kind =
regards</strong>,</span></p>
<p style=3D"line-height: 140%; margin: 0px;"><span style=3D"font-family: =
Montserrat, sans-serif; line-height: 19.6px;">The Business =
Investor</span></p>
<p style=3D"line-height: 140%; margin: 0px;"> </p>
<p style=3D"line-height: 140%; margin: 0px;"><span style=3D"color: =
rgb(0, 0, 0); font-family: Helvetica, Arial, sans-serif; font-size: =
11.2px; white-space: normal; float: none; display: inline; line-height: =
15.4px;">*If applicable<br>Disclaimer: Any person accessing the email =
and considering potential investment opportunities featured in the email =
should make their own commercial assessment after seeking the advice of =
an appropriately authorised or regulated financial adviser. This email =
should not be construed as advice or a personal recommendation to any =
prospective investor. Investments of this nature carry risks to your =
capital and can go up or down. Past performance is not indicative of =
future results. This opportunity is only suitable for high net worth or =
self-sophisticated investors as defined below. You have an annual income =
in excess of ?100K. Have net assets in excess of ?250K (excluding your =
pension funds and assets and your private residence). You have been a =
Director of a company turning over at least ?1 million within the last =
two years. You have made more than one investment in an unlisted company =
in the previous two years. You have been a member of a network or =
syndicate of business angels for at least six months. You have worked in =
the last two years in a professional capacity in the private equity =
sector or in the provision of finance for small and medium =
enterprises. </span></p>
</div>
</td>
</tr>
</tbody>
</table>
<!--[if (!mso)&(!IE)]><!--></div><!--<![endif]-->
</div>
</div>
<!--[if (mso)|(IE)]></td><![endif]-->
<!--[if (mso)|(IE)]></tr></table></td></tr></table><![endif]-->
</div>
</div>
</div>
=20
<!--[if (mso)|(IE)]></td></tr></table><![endif]-->
</td>
</tr>
</tbody>
</table>
<!--[if mso]></div><![endif]-->
<!--[if IE]></div><![endif]-->
<img =
src=3D"https://t.email.thebusinessinvestor.co.uk/t/2/IGDZOk1ySvSqUoJY4RgI=
XQ/PcKeWd47Kank8jXdULSpe7cAlGKZ-aYJswAL2XmwpVkGT1vWX-PQRzz-IRsMlesyAkZ8x1=
ajWLq1bi4Vcx7PCgbnNrmKBhUfpwBiPx99qzkeJJvABd4hoqMqnILf_-6ZeqS1w1O45w2SSuS=
wCrlPZwJm1Ek3cVFHW-6wfTaueos" =
style=3D"display:none;"></img></body><footer><div style=3D"text-align: =
center; background-color: white; padding: 10px;"><a =
href=3D"https://t.email.thebusinessinvestor.co.uk/u/2/UDJYrQvimamIVjBvyCx=
_ag/Fgp-C--y6adamaSdNtNqFWCPKJfzH_1MFACwnmC3BgChG9TcAirPEYQMRm7aA9S4m3fwS=
OBLPUFfhnvUqRiADo55-9mwAwhA9m2GmTcb4NS0-nUFNasNpgyDx6lzhSOT_wVejKaJ_pu8JL=
Gc1639GlskKB_bTw1gRXERncnUKsvILFV1sthPhvtrXuMfjI0f9GszM_Msr5jj1T4E1iDKXtb=
QkczE7OHyo0yZoz8reQv7S-DnqRJMJcfLKn5V4FYTHo-UtvTsrX0T8h9xHmAx1g">Unsubscr=
ibe</a><a =
href=3D"https://t.email.thebusinessinvestor.co.uk/s/2/1YobQm-K74m2weCeJuG=
4AQ/DFaWgeRop2RPS-o7CGi8lSL83l3pYixz7tC5nlJ_21UPEnqQLG-GF1NUC1EcO2ldBUjwM=
YY-mbCX1V55VTiHPkXUNV5wZKCpahDYNbAXQUmS6VlDS6_ZiRoSOAd5e78_ZkjeMckW4EUdUG=
89sE1Bn8vcTA3gD0lTHxVjXgn-kWRUAC2L7zgqFKcsgni4MZxCh6LpQZY_-dYbfFABrQEiWug=
tHPqwQIjqlfe5bDUW5rdCgtdCZgofYRkh60Thz6k9i8PoTLrKw3_xAzXAzSQ-og">Report =
Abuse</a></div></footer></html>
------=_NextPart_000_16FC_01DD0882.AE814120--